Gvoke 5 MG/ML per 0.2 ML Injection
- RxCUI
- 2587361
- RxNorm name
- Gvoke 5 MG/ML per 0.2 ML Injection
- Display name
- Gvoke 5 MG/ML per 0.2 ML Injection
- Full name
- Gvoke 5 MG/ML per 0.2 ML Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:08
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gvoke VialDx | GLUCAGON INJECTION | American Regent, Inc. | 359982a8-ec5c-4927-8c0f-89771e0f942b | 2026-07-07 | Warnings, Adverse reactions | 2587361 |
| Gvoke HypoPen 0.5 mg Auto-Injector | GLUCAGON INJECTION, SOLUTION | Xeris Pharmaceuticals, Inc. | 92385737-dbad-98c5-e053-2995a90a2805 | 2025-12-23 | Warnings, Adverse reactions | 2587361 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 92385737-dbad-98c5-e053-2995a90a2805 | Gvoke 1 MG in 0.2 ML Injection [PSN] · 0.2 ML glucagon 5 MG/ML Injection [Gvoke] [SBD] · Gvoke 1 MG per 0.2 ML Injection [SY] · Gvoke 5 MG/ML per 0.2 ML Injection [SY] | 4 | 20 | These highlights do not include all the information needed to use GVOKE and GVOKE VialDx safely and effectively. See full prescribing information for GVOKE and GVOKE VialDx. GVOKE (glucagon) injection, for subcutaneous use GVOKE VialDx (glucagon) injection, for intravenous use Initial U.S. Approval: 1960 | 20251223 |
| 359982a8-ec5c-4927-8c0f-89771e0f942b | Gvoke 1 MG in 0.2 ML Injection [PSN] · 0.2 ML glucagon 5 MG/ML Injection [Gvoke] [SBD] · Gvoke 1 MG per 0.2 ML Injection [SY] · Gvoke 5 MG/ML per 0.2 ML Injection [SY] | 4 | 1 | These highlights do not include all the information needed to use GVOKE and GVOKE VialDx safely and effectively. See full prescribing information for GVOKE and GVOKE VialDx. GVOKE (glucagon) injection, for subcutaneous use GVOKE VialDx (glucagon) injection, for intravenous use Initial U.S. Approval: 1960 | 20250301 |